Skip to main content

New Track-and-Trace Pilot Program Helps Manufacturers, Distributors, and Dispensers Meet DSCSA Requirements

By October 5, 2016March 8th, 2021Company News, DSCSA, Serialization, Track and Trace

West Bloomfield, Michigan — October 5, 2016 — LSPediA LLC, a leading software and service provider for the pharmaceutical industry, announced today the launch of RxChain, a new Track-and-Trace pilot program and serialization supply chain solution, to help pharmaceutical companies meet the requirements of the U.S. Food and Drug Administration’s Drug Supply Chain and Security Act (DSCSA). This software

Through its phased approach, the DSCSA outlines critical steps that companies in the pharmaceutical supply chain must undertake to build an electronic, interoperable system to identify, trace, and verify prescription drug products in the United States. This legislation is designed to secure the drug supply chain in the U.S., eliminate counterfeit drugs, and improve patient safety. From now to 2023, the pharmaceutical industry is required to implement serialized product identification, product verification, and interoperable product track-n-trace capabilities.

LSPediA’s RxChain is a new track-and-trace pilot program and serialization supply chain solution that is fully compliant with the requirements of DSCSA at its 2017 serialization phase, its 2019 wholesale distribution phase, and its 2023 interoperability phase.

RxChain is 90 percent more efficient than other track-n-trace solutions. This is achieved through enabling serialized data collection from both integrated data feeds and automated barcode scanners. At receiving, a built-in workflow will perform serialized quality inspection before receiving the inventory and accepting the data feed. At shipping, units and cases are scanned-out and their data captured for future verification and reporting. In addition, its verification function allows downstream trading partners to verify serialized products at their source without building out an elaborate data warehouse.

“Many serialization pilots have revealed that the industry needs a better model to track-n-trace serialized products,” stated Riya Cao, CEO, LSPediA. “RxChain provides the capabilities that manufacturers, wholesalers, and dispensers need to identify, trace, and verify serialized drug products. In addition, our solution provides the robust functionality that enables secure and efficient product returns, and suspect and illegitimate product reporting, that help protect patient safety.”


About LSPediA – Life Sciences Solutions

LSPediA is a leading provider of enterprise software and services designed for pharmaceutical manufacturers, wholesale distributors, and dispensers. With LSPediA, customers can better implement serialization and aggregation processes to meet global regulations, DSCSA requirements, and future track-and-trace mandates.

We value long-term relationships and work with our clients’ internal teams to properly define roadmaps, create architectures, and implement systems that align to vital business goals, ultimately helping them derive maximum value from their investments, both now and well into the future.

For more information about LSPediA, call +1 (248) 973-2008, email [email protected], or visit our website at

For additional information, contact: Julianne Jahn [email protected]